| P50 | author | O Trohatou | Q64515142 |
| P2093 | author name string | Ioannis Kalaitzopoulos | |
| | Nicholas P Anagnou | |
| | Apostolos Roubelakis | |
| | Maria G Roubelakis | |
| | Georgios Papazoglou | |
| | Kalliopi I Pappa | |
| | Evgenia Mili | |
| P2860 | cites work | Wound healing--aiming for perfect skin regeneration | Q29616715 |
| | Cutaneous wound healing | Q29618894 |
| | Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol | Q30164154 |
| | Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells | Q33307769 |
| | Characterization of ligand binding to N-acetylglucosamine kinase studied by STD NMR. | Q33384187 |
| | Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair | Q33987579 |
| | Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides | Q34285372 |
| | Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues | Q34333323 |
| | Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice | Q34360080 |
| | Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization | Q34566545 |
| | Human gingival fibroblast migration promoted by platelet-derived growth factor on titanium is correlated with release of urokinase type plasminogen activator | Q73340383 |
| | Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation | Q73756569 |
| | The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study | Q80260174 |
| | Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells | Q80403767 |
| | A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers | Q81687646 |
| | Proangiogenic soluble factors from amniotic fluid stem cells mediate the recruitment of endothelial progenitors in a model of ischemic fasciocutaneous flap | Q83190456 |
| | Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation | Q84029874 |
| | Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing | Q84594884 |
| | Isolation of amniotic stem cell lines with potential for therapy | Q34598404 |
| | Wharton's jelly-derived cells are a primitive stromal cell population | Q35849157 |
| | Wound healing and its impairment in the diabetic foot | Q36314100 |
| | Intradermal adipocytes mediate fibroblast recruitment during skin wound healing | Q36682969 |
| | AF-MSCs fate can be regulated by culture conditions | Q36890227 |
| | Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. | Q36997844 |
| | Mesenchymal stem cell-derived microvesicles protect against acute tubular injury | Q37176871 |
| | Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. | Q37309463 |
| | Treatment with bone marrow-derived stromal cells accelerates wound healing in diabetic rats | Q37367824 |
| | In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. | Q37568639 |
| | Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide | Q37756932 |
| | Mesenchymal stromal cells: facilitators of successful transplantation? | Q37796056 |
| | Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus | Q37833577 |
| | The potential of amniotic fluid stem cells for cellular therapy and tissue engineering | Q37881973 |
| | Human amniotic fluid stem cells as an attractive tool for clinical applications. | Q38058886 |
| | Fetal mesenchymal stem cells in cancer therapy | Q38061962 |
| | Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer | Q38452601 |
| | Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells | Q38492965 |
| | A novel function for the haemopoietic supportive murine bone marrow MS-5 mesenchymal stromal cell line in promoting human vasculogenesis and angiogenesis. | Q39398270 |
| | Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: a novel approach for the treatment of bladder cancer. | Q39460127 |
| | Treatment of nonhealing diabetic lower extremity ulcers with skin graft and autologous platelet gel: a case series | Q39847980 |
| | Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury | Q39912598 |
| | Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells | Q40370235 |
| | Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? | Q40578057 |
| | Amniotic fluid and amniotic membrane stem cells: marker discovery. | Q42196647 |
| | Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing | Q43789362 |
| | Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications | Q43898390 |
| | Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. | Q43944175 |
| | Therapeutic potential of fetal mesenchymal stem cells | Q43967412 |
| | OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer | Q44197586 |
| | Therapeutic potential of a distinct population of human amniotic fluid mesenchymal stem cells and their secreted molecules in mice with acute hepatic failure. | Q45180763 |
| | High transduction efficiency of circulating first trimester fetal mesenchymal stem cells: potential targets for in utero ex vivo gene therapy | Q45888787 |
| | 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies | Q46537146 |
| | Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. | Q47970094 |
| | Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. | Q48515308 |
| | Topical lineage-negative progenitor-cell therapy for diabetic wounds | Q48870647 |
| | Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. | Q50674319 |
| | Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. | Q50998404 |
| | Bone marrow-derived mesenchymal stem cells enhanced diabetic wound healing through recruitment of tissue regeneration in a rat model of streptozotocin-induced diabetes. | Q53219175 |
| | A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. | Q55042128 |
| | Use of autologous platelet concentrate in a nonhealing lower extremity wound. | Q55042391 |
| | Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. | Q55057379 |
| P433 | issue | 3 | |
| P921 | main subject | cell migration | Q189092 |
| | wound healing | Q1509074 |
| | wound healing process | Q126110222 |
| P304 | page(s) | 417-428 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Stem Cell Reviews and Reports | Q7607285 |
| P1476 | title | Platelet-rich plasma (PRP) promotes fetal mesenchymal stem/stromal cell migration and wound healing process | |
| P478 | volume | 10 | |